Home > HP (current issue) > News and features / News Centre | Search

PJ Online homeHospital Pharmacist
2005;12:428
December 2005

Hospital Pharmacist back issues

News summary


NICE consults on new guideline proposals

Proposed changes to the process of developing clinical guidelines have been published by the National Institute for Health and Clinical Excellence.

In order to make the guideline development process more efficient and in response to comments received from guideline developers, stakeholders and the wider public, NICE proposes changes in the following areas: the process by which stakeholders are asked to submit evidence; the consultation process with stakeholders; external validation; the process for updating guidelines and removing the classification from the recommendations.

Following a survey showing that few submissions received by NICE identified evidence that had not already been sourced by the relevant National Collaborating Centre, it is proposed that the NCC developing the guideline will call for evidence on specific questions after it has performed initial searches. “In confidence” data will now also be accepted as evidence.

Draft guidelines are currently consulted on for two periods of four weeks. NICE now proposes to publish one draft guideline for an eight week consultation period, and to no longer consult on the information for the public version of the guideline.

NICE proposes that NCCs will be encouraged to consider arranging their own peer review of their guidelines. NICE will commission in-depth peer reviews of all guidelines.

A more flexible approach to updating the guidelines is proposed so that they can be updated at any point after publication to reflect changes in evidence base. Partial updates rather than full updates are proposed after four years.

NICE also proposes that the current guideline classification system will no longer be used, following concerns that translating strength of evidence into a recommendation may hide important details

The proposals can be accessed via the NICE website. The consultation closes on 17 February 2006.

Back to Top


©The Pharmaceutical Journal